BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1627802)

  • 1. Transcellular metabolism of arachidonic acid: increased platelet thromboxane generation in the presence of activated polymorphonuclear leukocytes.
    Maugeri N; Evangelista V; Piccardoni P; Dell'Elba G; Celardo A; de Gaetano G; Cerletti C
    Blood; 1992 Jul; 80(2):447-51. PubMed ID: 1627802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphonuclear leukocyte-platelet interaction: role of P-selectin in thromboxane B2 and leukotriene C4 cooperative synthesis.
    Maugeri N; Evangelista V; Celardo A; Dell'Elba G; Martelli N; Piccardoni P; de Gaetano G; Cerletti C
    Thromb Haemost; 1994 Sep; 72(3):450-6. PubMed ID: 7531878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinases.
    Evangelista V; Rajtar G; de Gaetano G; White JG; Cerletti C
    Blood; 1991 Jun; 77(11):2379-88. PubMed ID: 1645603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference of recombinant eglin C, a proteinase inhibitor extracted from leeches, with neutrophil-mediated platelet activation.
    Renesto P; Ferrer-Lopez P; Chignard M
    Lab Invest; 1990 Apr; 62(4):409-16. PubMed ID: 2159081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin G-dependent platelet stimulation by activated polymorphonuclear leukocytes and its inhibition by antiproteinases: role of P-selectin-mediated cell-cell adhesion.
    Evangelista V; Piccardoni P; White JG; de Gaetano G; Cerletti C
    Blood; 1993 Jun; 81(11):2947-57. PubMed ID: 7684621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphonuclear leukocyte-dependent modulation of platelet function: effect of cloricromene.
    Zatta A; Prosdocimi M; Bazzoni G; Dejana E; Del Maschio A
    Eur J Pharmacol; 1991 May; 198(1):97-100. PubMed ID: 1833211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in platelet-polymorphonuclear leukocyte interaction.
    de Gaetano G; Cerletti C; Evangelista V
    Haemostasis; 1999 Sep; 29(1):41-9. PubMed ID: 10494033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin inhibits neutrophil-induced platelet activation via cathepsin G.
    Ferrer-Lopez P; Renesto P; Prevost MC; Gounon P; Chignard M
    J Lab Clin Med; 1992 Mar; 119(3):231-9. PubMed ID: 1541873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of polymorphonuclear leukocytes on the metabolism of arachidonate in human platelets.
    Oudinet JP; Sraer J; Bens M; Ardaillou R
    Thromb Haemost; 1988 Aug; 60(1):59-62. PubMed ID: 3142092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
    Liao CH; Cheng JT; Teng CM
    Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils.
    Bleasdale JE; Thakur NR; Gremban RS; Bundy GL; Fitzpatrick FA; Smith RJ; Bunting S
    J Pharmacol Exp Ther; 1990 Nov; 255(2):756-68. PubMed ID: 2147038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-alpha enhances platelet activation via cathepsin G released from neutrophils.
    Renesto P; Chignard M
    J Immunol; 1991 Apr; 146(7):2305-9. PubMed ID: 2005399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G.
    Ferrer-Lopez P; Renesto P; Schattner M; Bassot S; Laurent P; Chignard M
    Am J Physiol; 1990 Jun; 258(6 Pt 1):C1100-7. PubMed ID: 2360620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of co-incubation and cell number of platelets and polymorphonuclear leukocytes in cellular inhibition and activation phenomena.
    Hernández R; Alemany M; Bozzo J; Ordinas A; Bastida E
    Thromb Res; 1994 May; 74(3):255-63. PubMed ID: 8042192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of cathepsin G-induced platelet activation by leukocyte elastase: consequence for the neutrophil-mediated platelet activation.
    Renesto P; Chignard M
    Blood; 1993 Jul; 82(1):139-44. PubMed ID: 8324217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents.
    Del Maschio A; Evangelista V; Rajtar G; Chen ZM; Cerletti C; De Gaetano G
    Am J Physiol; 1990 Mar; 258(3 Pt 2):H870-9. PubMed ID: 2156456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arachidonic acid metabolism by platelets of differing size.
    Jakubowski JA; Thompson CB; Vaillancourt R; Valeri CR; Deykin D
    Br J Haematol; 1983 Mar; 53(3):503-11. PubMed ID: 6402003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defibrotide inhibits platelet activation by cathepsin G released from stimulated polymorphonuclear leukocytes.
    Evangelista V; Piccardoni P; de Gaetano G; Cerletti C
    Thromb Haemost; 1992 Jun; 67(6):660-4. PubMed ID: 1509406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential potentiation and inhibition of PMN reactivity by maximally stimulated platelets.
    Aziz KA; Cawley JC; Treweeke AT; Zuzel M
    J Leukoc Biol; 1997 Mar; 61(3):322-8. PubMed ID: 9060455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eicosanoid production from porcine neutrophils and platelets: differential production with various agonists.
    Stahl GL; Morse DS; Martin SL
    Am J Physiol; 1997 Jun; 272(6 Pt 1):C1821-8. PubMed ID: 9227410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.